|
VVOS Vivos Therapeutics Inc 1716166 |
| Balance Sheet |
|
Current Assets
|
$4,213,000.00 |
|
Assets
|
$24,144,000.00 |
|
Current Liabilities
|
$20,389,000.00 |
|
Liabilities
|
$28,130,000.00 |
|
Equity
|
$-3,815,000.00 |
|
Shares Out
|
14531617.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-9,158,000.00 |
|
Investing Cash Flow
|
$-434,000.00 |
| Market Analysis |
Market Cap
|
$4,068,852.76 |
|
Price
|
$0.28 |
|
PB
|
4.47 |
|
EPS
|
-0.31 |
|
PS
|
0.20 |
|
FCF
|
$-9,592,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:02 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:52 |
|
| Apr |
May |
Jun |
|
|
2026-04-15 |
-2.07 |
2026-05-20 |
-0.52 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-19 |
-0.55 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-19 |
-0.49 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VVOS documents filed with the SEC.
VVOS Filings
Clear
